Curis Highlights Publication in ACS Medicinal Chemistry Letters Showcasing Targeted Potency and Ideal Pharmacologic Properties of CA-4948 for Treatment of Hematologic Malignancies

Stock Information for Curis Inc.

Loading

Please wait while we load your information from QuoteMedia.